These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31488250)

  • 1. Age-Dependent Prognostic Impact of Paroxysmal Versus Sustained Atrial Fibrillation on the Incidence of Cardiac Death and Heart Failure Hospitalization (the Fushimi AF Registry).
    An Y; Ogawa H; Esato M; Ishii M; Iguchi M; Masunaga N; Aono Y; Ikeda S; Doi K; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M;
    Am J Cardiol; 2019 Nov; 124(9):1420-1429. PubMed ID: 31488250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry.
    Esato M; Chun YH; An Y; Ogawa H; Wada H; Hasegawa K; Tsuji H; Abe M; Lip GYH; Akao M
    Chest; 2017 Dec; 152(6):1266-1275. PubMed ID: 28823813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Events and Mortality in Patients With Atrial Fibrillation and Anemia (from the Fushimi AF Registry).
    An Y; Ogawa H; Esato M; Ishii M; Iguchi M; Masunaga N; Fujino A; Ide Y; Hamatani Y; Doi K; Ikeda S; Ishigami K; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M;
    Am J Cardiol; 2020 Nov; 134():74-82. PubMed ID: 32900468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of left ventricular ejection fraction in atrial fibrillation patients without pre-existing heart failure.
    Hamatani Y; Iguchi M; Minami K; Ishigami K; Esato M; Tsuji H; Wada H; Hasegawa K; Ogawa H; Abe M; Lip GYH; Akao M;
    ESC Heart Fail; 2023 Oct; 10(5):3091-3101. PubMed ID: 37604489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry.
    Takabayashi K; Hamatani Y; Yamashita Y; Takagi D; Unoki T; Ishii M; Iguchi M; Masunaga N; Ogawa H; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GY; Akao M
    Stroke; 2015 Dec; 46(12):3354-61. PubMed ID: 26514188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Regression from Sustained to Paroxysmal Atrial Fibrillation with Clinical Outcomes: The Fushimi AF Registry.
    Esato M; Fujino A; Hamatani Y; Yoshizawa T; Ide Y; Ishii M; Iguchi M; Masunaga N; Wada H; Hasegawa K; Tsuji H; Abe M; Akao M
    Am J Cardiol; 2024 Sep; 227():37-47. PubMed ID: 38936788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events.
    Ogawa H; An Y; Ikeda S; Aono Y; Doi K; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M;
    Stroke; 2018 Oct; 49(10):2301-2308. PubMed ID: 30355097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry.
    An Y; Esato M; Ishii M; Iguchi M; Masunaga N; Tsuji H; Wada H; Hasegawa K; Ogawa H; Abe M; Lip GYH; Akao M
    Heart Vessels; 2018 Dec; 33(12):1534-1546. PubMed ID: 29797059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-Related Differences in the Clinical Events of Patients With Atrial Fibrillation　- The Fushimi AF Registry.
    Ogawa H; Hamatani Y; Doi K; Tezuka Y; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GY; Akao M;
    Circ J; 2017 Sep; 81(10):1403-1410. PubMed ID: 28539562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation　- The Fushimi AF Registry.
    Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
    Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuria is independently associated with heart failure events in patients with atrial fibrillation: the Fushimi AF registry.
    Ikeda S; An Y; Iguchi M; Ogawa H; Nakanishi Y; Minami K; Ishigami K; Aono Y; Doi K; Hamatani Y; Yoshizawa T; Ide Y; Fujino A; Ishii M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M
    Eur Heart J Qual Care Clin Outcomes; 2023 Dec; 9(8):758-767. PubMed ID: 36611235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Impact of Resting Heart Rate on Adverse Events in Paroxysmal and Sustained Atrial Fibrillation　- The Fushimi AF Registry.
    Iguchi M; Hamatani Y; Sugiyama H; Ishigami K; Aono Y; Ikeda S; Doi K; Fujino A; An Y; Ishii M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Ogawa H; Abe M; Akao M;
    Circ J; 2020 Nov; 84(12):2138-2147. PubMed ID: 33055472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation type and long-term clinical outcomes in hospitalized patients with heart failure: insight from JROADHF.
    Hamatani Y; Enzan N; Iguchi M; Yoshizawa T; Kawaji T; Ide T; Tohyama T; Matsushima S; Abe M; Tsutsui H; Akao M
    Eur Heart J Qual Care Clin Outcomes; 2024 May; 10(3):193-202. PubMed ID: 38236704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    Mogensen UM; Jhund PS; Abraham WT; Desai AS; Dickstein K; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Køber L; McMurray JJV;
    J Am Coll Cardiol; 2017 Nov; 70(20):2490-2500. PubMed ID: 29145948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry.
    An Y; Ogawa H; Yamashita Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M
    Eur Heart J Qual Care Clin Outcomes; 2019 Jan; 5(1):35-42. PubMed ID: 30020445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and outcomes of dialysis patients with atrial fibrillation: the Fushimi AF Registry.
    Yamashita Y; Takagi D; Hamatani Y; Iguchi M; Masunaga N; Esato M; Chun YH; Itoh H; Nishimura M; Wada H; Hasegawa K; Ogawa H; Abe M; Akao M
    Heart Vessels; 2016 Dec; 31(12):2025-2034. PubMed ID: 26973346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and Risk Factors of Stroke or Systemic Embolism in Patients With Atrial Fibrillation and Heart Failure　- The Fushimi AF Registry.
    Iguchi M; Tezuka Y; Ogawa H; Hamatani Y; Takagi D; An Y; Unoki T; Ishii M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M
    Circ J; 2018 Apr; 82(5):1327-1335. PubMed ID: 29526914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics and Outcomes in Extreme Elderly (Age ≥ 85 Years) Japanese Patients With Atrial Fibrillation: The Fushimi AF Registry.
    Yamashita Y; Hamatani Y; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M
    Chest; 2016 Feb; 149(2):401-412. PubMed ID: 26181726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.